Pharmacokinetic correlates of venlafaxine: associated adverse reactions
To address the potential correlation between plasma concentrations of venlafaxine (VEN), its active metabolite O-desmethylvenlafaxine (ODVEN) and the active moiety, AM, (ODVEN + VEN) and adverse drug reactions (ADR) in a large naturalistic sample of in- and outpatients. We compared plasma concentrat...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 March 2019
|
| In: |
European archives of psychiatry and clinical neuroscience
Year: 2019, Jahrgang: 269, Heft: 7, Pages: 851-857 |
| ISSN: | 1433-8491 |
| DOI: | 10.1007/s00406-019-01005-0 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1007/s00406-019-01005-0
|
| Verfasserangaben: | Georgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, Katharina Endres, Florian Ridders, Tanja Veselinovic, Gerhard Gründer, Michael Paulzen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1677987545 | ||
| 003 | DE-627 | ||
| 005 | 20230428021913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191001s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00406-019-01005-0 |2 doi | |
| 035 | |a (DE-627)1677987545 | ||
| 035 | |a (DE-599)KXP1677987545 | ||
| 035 | |a (OCoLC)1341244563 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schoretsanitēs, Geōrgios |d 1953- |e VerfasserIn |0 (DE-588)1169687679 |0 (DE-627)1035290197 |0 (DE-576)512198446 |4 aut | |
| 245 | 1 | 0 | |a Pharmacokinetic correlates of venlafaxine |b associated adverse reactions |c Georgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, Katharina Endres, Florian Ridders, Tanja Veselinovic, Gerhard Gründer, Michael Paulzen |
| 264 | 1 | |c 28 March 2019 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.10.2019 | ||
| 520 | |a To address the potential correlation between plasma concentrations of venlafaxine (VEN), its active metabolite O-desmethylvenlafaxine (ODVEN) and the active moiety, AM, (ODVEN + VEN) and adverse drug reactions (ADR) in a large naturalistic sample of in- and outpatients. We compared plasma concentrations of VEN, ODVEN and AM and dose-adjusted (C/D) levels as well the ODVEN/VEN ratios between patients complaining ADRs, following the Udvalg for Kliniske Undersogelser side effect rating scales (UKU) (n = 114) and patients without ADRs (control group, n = 688) out of a naturalistic database. We also investigated potential pharmacokinetic correlates of the four UKU categories by comparing patients complaining ADRs with those who did not. Based on previous literature we applied different ODVEN/VEN ratio values as cut-offs to split our sample into two groups at a time and compare frequencies of ADRs between the groups. No differences for demographic and pharmacokinetic variables including plasma and C/D concentrations as well as ODVEN/VEN ratios were observed between study groups. Neither the comparisons between females and males nor between elderly and non-elderly patients revealed significant differences (p > 0.05 in all cases). No differences were also reported exploring the patients complaining ADRs from the 4 UKU categories separately. After applying various ODVEN/VEN cut-offs, groups did not display differences in frequencies of ADRs (p > 0.05 in all cases). Our findings do not demonstrate a direct link between venlafaxine metabolism measures and ADRs. Therefore, additional dimensions are needed to be considered in future trials aiming to disentangle the involved aspects of ADRs in patients receiving venlafaxine. | ||
| 650 | 4 | |a Adverse drug reactions | |
| 650 | 4 | |a Antidepressants | |
| 650 | 4 | |a Drug metabolism | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a Psychopharmacology | |
| 700 | 1 | |a Gründer, Gerhard |e VerfasserIn |0 (DE-588)1078251037 |0 (DE-627)838195350 |0 (DE-576)449927644 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European archives of psychiatry and clinical neuroscience |d Darmstadt : Steinkopff, 1868 |g 269(2019), 7, Seite 851-857 |h Online-Ressource |w (DE-627)253722691 |w (DE-600)1459045-1 |w (DE-576)072372559 |x 1433-8491 |7 nnas |a Pharmacokinetic correlates of venlafaxine associated adverse reactions |
| 773 | 1 | 8 | |g volume:269 |g year:2019 |g number:7 |g pages:851-857 |g extent:7 |a Pharmacokinetic correlates of venlafaxine associated adverse reactions |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00406-019-01005-0 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20191001 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1078251037 |a Gründer, Gerhard |m 1078251037:Gründer, Gerhard |d 60000 |e 60000PG1078251037 |k 0/60000/ |p 7 | ||
| 999 | |a KXP-PPN1677987545 |e 3519225484 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Pharmacokinetic correlates of venlafaxine","subtitle":"associated adverse reactions","title_sort":"Pharmacokinetic correlates of venlafaxine"}],"name":{"displayForm":["Georgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, Katharina Endres, Florian Ridders, Tanja Veselinovic, Gerhard Gründer, Michael Paulzen"]},"person":[{"role":"aut","given":"Geōrgios","display":"Schoretsanitēs, Geōrgios","family":"Schoretsanitēs"},{"family":"Gründer","given":"Gerhard","role":"aut","display":"Gründer, Gerhard"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1677987545","origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"28 March 2019"}],"relHost":[{"disp":"Pharmacokinetic correlates of venlafaxine associated adverse reactionsEuropean archives of psychiatry and clinical neuroscience","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["253722691"],"issn":["1433-8491"],"zdb":["1459045-1"]},"note":["Zusatz teils: official organ of the German Society for Biological Psychiatry","Ungezählte Beil.: Supplement"],"titleAlt":[{"title":"Psychiatry and clinical neuroscience"},{"title":"Archiv für Psychiatrie und Nervenkrankheiten"},{"title":"European archives of psychiatry and neurological sciences"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Darmstadt ; Berlin ; Heidelberg","dateIssuedDisp":"1868-","publisher":"Steinkopff ; Springer","dateIssuedKey":"1868"}],"recId":"253722691","title":[{"title":"European archives of psychiatry and clinical neuroscience","title_sort":"European archives of psychiatry and clinical neuroscience"}],"part":{"extent":"7","pages":"851-857","issue":"7","volume":"269","year":"2019","text":"269(2019), 7, Seite 851-857"},"language":["eng"],"pubHistory":["1.1868/69 -"]}],"note":["Gesehen am 01.10.2019"],"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1007/s00406-019-01005-0"],"eki":["1677987545"]}} | ||
| SRT | |a SCHORETSANPHARMACOKI2820 | ||